Submucous Fibrosis (Oral)
Oral submucous fibrosis is a constant, complex, premalignant (1% change hazard) state of the oral depression, described by juxta-epithelial incendiary response and dynamic fibrosis of the submucosal
tissues (the lamina propria and more profound connective tissues). As the
infection advances, the jaws become unbending to the point that the individual can't open the mouth. The condition is remotely connected to oral
tumors and is related with areca nut and/or its side-effects biting, significantly rehearsed in South and South-East Asian nations. The rate of OSMF has likewise expanded in the western nations because of the changing propensities and consistent moving populace. In the underlying period of the sickness, the mucosa feels rugged with tangible fibrotic groups. In the propelled stage the oral mucosa loses its flexibility and gets whitened and hardened. The sickness is accepted to start in the back piece of the oral hole and progressively spread outward. This excessive touchiness response brings about a juxta-epithelial irritation that prompts expanded fibroblastic action and diminished breakdown of strands. The fibroblasts are phenotypically adjusted, and the filaments they structure are increasingly steady, produce thicker groups that continuously gotten less versatile. when the first approximately masterminded stringy tissue is supplanted by the progressing fibrosis, the mobility of the oral
tissues is diminished, there is loss of adaptability and decreased opening of the mouth. These collagen filaments are non degradable and the phagocytic movement is limited.
High Impact List of Articles
-
Chemokine receptor-like 2 is involved in ischemic brain injury
Robert M. Douglas, Alice H. Chen, Alejandra Iniguez, Juan Wang, Zhengxing Fu, Frank L. Powell Jr., Gabriel G. Haddad and Hang Yao
Research Article: Journal of Experimental Stroke & Translational Medicine
-
Chemokine receptor-like 2 is involved in ischemic brain injury
Robert M. Douglas, Alice H. Chen, Alejandra Iniguez, Juan Wang, Zhengxing Fu, Frank L. Powell Jr., Gabriel G. Haddad and Hang Yao
Research Article: Journal of Experimental Stroke & Translational Medicine
-
Targeting ischemic penumbra Part II: selective drug delivery using liposome technologies
Shimin Liu, Steven R. Levine and H. Richard Winn
Review Article: Journal of Experimental Stroke & Translational Medicine
-
Targeting ischemic penumbra Part II: selective drug delivery using liposome technologies
Shimin Liu, Steven R. Levine and H. Richard Winn
Review Article: Journal of Experimental Stroke & Translational Medicine
-
Towards a dynamical network view of brain ischemia and reperfusion. Part III: therapeutic implications
Donald J. DeGracia
Review Article: Journal of Experimental Stroke & Translational Medicine
-
Towards a dynamical network view of brain ischemia and reperfusion. Part III: therapeutic implications
Donald J. DeGracia
Review Article: Journal of Experimental Stroke & Translational Medicine
-
Long-term survival and serial assessment of stroke damage and recovery practical and methodological considerations
Michel Modo
Review Article: Journal of Experimental Stroke & Translational Medicine
-
Long-term survival and serial assessment of stroke damage and recovery practical and methodological considerations
Michel Modo
Review Article: Journal of Experimental Stroke & Translational Medicine
-
Chronic treatment with Losartan and Cerebral Ischemic Tolerance
Zonghang Zhao, Ursula I. Tuor and Phil Barber
Research Article: Journal of Experimental Stroke & Translational Medicine
-
Chronic treatment with Losartan and Cerebral Ischemic Tolerance
Zonghang Zhao, Ursula I. Tuor and Phil Barber
Research Article: Journal of Experimental Stroke & Translational Medicine
Relevant Topics in Clinical